证券日报网讯 1月9日，晓鸣股份发布公告称，2025年12月公司销售鸡产品2252.52万羽，实现销售收入 6603.37万元，环比分别增长18.30%和41.51%，同比仍下降20.37%和37.07%。 （文章来源：证券日报） ...

Group 1 - China Shipbuilding Defense expects a net profit of 940 million to 1.12 billion yuan for 2025, an increase of 149.61% to 196.88% year-on-year [1] - China First Heavy Industries has only undertaken a small number of related accessory projects and has not generated revenue from them [2] - Huanyu Electronics plans to invest 30 million yuan in a private equity fund focused on AI and emerging industries [3] Group 2 - Zhixiang Jintai's GR1803 injection has been included in the priority review list by the National Medical Products Administration [4] - JianKai Technology's shareholder plans to reduce holdings by up to 3% of the company's shares [5] - Debon Holdings will continue to suspend trading from January 12 due to significant matters being planned [6] Group 3 - South Network Technology's shareholder intends to transfer 847.05 million shares, accounting for 1.50% of the total share capital [7] - Hengrui Medicine has received approval for clinical trials of four drugs [8] - Daotong Technology expects a net profit of 900 million to 930 million yuan for 2025, a year-on-year increase of 40.42% to 45.10% [10] Group 4 - Betta Pharmaceuticals has invested 50 million yuan to acquire a 20% stake in Hangzhou Zhixing Pharmaceutical [11] - Tianyu Biology reported a 10.38% year-on-year decline in cumulative sales revenue for 2025 [12] - Lifang Pharmaceutical's subsidiary has obtained a drug registration certificate for a pain relief product [13] Group 5 - R&F Properties reported a total sales revenue of approximately 14.21 billion yuan for 2025 [14] - Wanfu Biology expects a net profit decline of 87.71% to 91.81% for 2025 [15] - Dazhi expects a negative net profit for 2025 [16] Group 6 - Dongzhu Ecology is negotiating to terminate the acquisition of control over a satellite communication company [17] - Baotai has received a milestone payment of 10 million USD from Hikma Pharmaceuticals [18] - Huace Navigation expects a net profit of 670 million to 690 million yuan for 2025, a year-on-year increase of 14.84% to 18.27% [19] Group 7 - Shenzhen Gas reported a net profit decline of 3.45% for 2025 [20] - Baogang Co. plans to adjust the price of rare earth concentrate for Q1 2026 to 26,834 yuan per ton [21] - Jiuding Investment expects to report a loss for 2025 [22] Group 8 - Shanghai Pharmaceuticals has received a drug registration certificate for a treatment for myasthenia gravis [23] - Hualan Biological plans to acquire a 35% stake in Guangfeng Capsule [24] - Ruina Intelligent plans to invest 169.9 million yuan in a new R&D production base for heat pumps [25] Group 9 - Wantong Development expects to report a loss for 2025 [26] - Xianghe Industrial has completed the purchase of a 5% stake in Hezhixiang Technology [27] - Guangkang Biochemical received a warning letter from the Guangdong Securities Regulatory Commission [28] Group 10 - Xiaoming Co. reported a 37.07% year-on-year decline in chicken product sales revenue for December 2025 [29] - Luokai Co. won a procurement project from State Grid Fujian Power worth approximately 48.2 million yuan [30] - Minhe Co. reported a 65.22% year-on-year increase in the sales of commodity chick seedlings for December 2025 [31] Group 11 - Zhenghai Biological has obtained a registration certificate for calcium silicate bio-ceramic materials [32] - Three Gorges Energy reported a 5.99% year-on-year increase in cumulative total power generation for 2025 [33] - Huisheng Biological expects a net profit of 235 million to 271 million yuan for 2025 [34] Group 12 - Maihe Co. announced the release of the detention measures against its chairman [35] - Wandong's Alzheimer's project has been included in a national major special project for innovative drug development [36] - Kangxin New Materials plans to transfer forest land assets with a book value of 1.203 billion yuan [37] Group 13 - Greenland Holdings expects a net loss of 16 billion to 19 billion yuan for 2025 [39] - Zhongxin Fluorine Materials has obtained a pesticide production license [40]

Core Viewpoint - The company reported significant month-on-month increases in chicken product sales volume and revenue, but year-on-year figures show a decline due to industry challenges such as supply-demand imbalance and low prices [1] Group 1: Sales Performance - In December 2025, the company sold 22.5252 million chickens, generating revenue of 66.0337 million yuan, with month-on-month changes of 18.30% and 41.51% respectively [1] - The average selling price for the month was 2.93 yuan per chicken [1] Group 2: Industry Challenges - Year-on-year sales volume and revenue decreased by 20.37% and 37.07% respectively, indicating significant pressure from the industry [1] - High inventory levels of laying hens have led to notable supply pressure, while market consumption remains weak [1] - Continuous losses in chicken farming and weak pig prices are further suppressing the demand for chicken products [1]

智通财经APP讯，晓鸣股份(300967.SZ)公告，公司2025年12月销售鸡产品2252.52万羽，销售收入 6603.37万元，环比变动分别为18.30%、41.51%，同比变动分别为-20.37%、-37.07%。 ...

Core Viewpoint - The company reported significant month-on-month growth in chicken product sales and revenue for December 2025, but year-on-year comparisons reveal ongoing challenges in the industry due to supply-demand imbalances and low prices [1]. Company Summary - In December 2025, the company sold 22.5252 million chickens, generating sales revenue of 66.0337 million yuan [1]. - Month-on-month changes for sales volume and revenue were 18.30% and 41.51%, respectively [1]. - Year-on-year changes showed a decline in sales volume and revenue of -20.37% and -37.07%, respectively [1]. Industry Summary - The industry continues to face dual pressures from a phase of supply-demand imbalance and persistently low prices [1].

二、原因说明 2025 年 12 月，公司鸡产品销售数量与销售收入环比均实现较大幅度提升。 然而，从同比角度看，行业整体仍受阶段性供需失衡与价格持续低迷的双重压力。 当前，全国在产蛋鸡存栏量依旧处于历史相对高位，供给压力依然显著。尽管春 节前季节性需求提振初步显现，但整体市场消费仍显平淡。与此同时，蛋鸡养殖 持续处于亏损区间，养殖单位对后市预期趋于谨慎，补栏积极性虽略有回暖，但 价格端仍承受较大压力。此外，生猪价格走势偏弱，也从一定程度上抑制了鸡蛋 的替代性消费需求。 证券代码：300967 证券简称：晓鸣股份 公告编号：2026-003 宁夏晓鸣农牧股份有限公司 2025 年 12 月鸡产品销售情况简报 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、2025 年 12 月鸡产品销售情况 宁夏晓鸣农牧股份有限公司（以下简称"公司"）2025 年 12 月销售鸡产品 2,252.52 万羽，销售收入 6,603.37 万元，环比变动分别为 18.30%、41.51%，同 比变动分别为-20.37%、-37.07%。 3、公司指定的信息披露媒体为巨潮资讯网（ ...

证券日报网讯1月6日，晓鸣股份（300967）发布公告称，截至2025年12月31日，公司通过回购专用证券 账户以集中竞价交易方式累计回购股份数量为1，895，100股，占总股本1.0103%，成交区间11.23元/股 至19.18元/股，已支付21，993，238.00元(不含交易费用)。 ...

格隆汇1月6日丨晓鸣股份(300967.SZ)公布，截至2025年12月31日，公司通过回购专用证券账户以集中 竞价交易方式累计回购股份数量为1,895,100股，占公司总股本的1.0103%，成交的最低价格为11.23元/ 股，成交的最高价格为19.18元/股，支付的总金额为人民币21,993,238.00元（不含交易费用）。上述回 购符合公司回购方案及相关法律法规的要求。 ...

每经头条（nbdtoutiao）——原指导价34.99万的宝马裸车价22.5万元，多家车企还补贴购置税！2026开 年车市火爆，销售从早到晚忙到没空吃饭 （记者 王晓波） 每经AI快讯，晓鸣股份1月6日晚间发布公告称，截至2025年12月31日，公司通过回购专用证券账户以 集中竞价交易方式累计回购股份数量约为190万股，占公司总股本的1.0103%，成交的最低价格为11.23 元/股，成交的最高价格为19.18元/股，支付的总金额为人民币约2199万元。 ...

关于回购公司股份的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宁夏晓鸣农牧股份有限公司（以下简称"公司"）于 2024 年 12 月 20 日召 开第五届董事会第十七次会议、第五届监事会第七次会议，于 2025 年 1 月 10 日召开 2025 年第一次临时股东大会逐项审议通过《关于回购公司股份方案的议 案》，公司将使用自有资金和/或自筹资金通过二级市场以集中竞价交易方式回 购部分公司已在境内发行上市的人民币普通股（A 股）股票，用于实施员工持股 计划或股权激励计划。 本次回购总金额不低于人民币 2,000.00 万元（含）且不超过人民币 4,000.00 万元（含），回购股份的价格不超过 19.74 元/股。具体回购数量以回购期限届 满时实际回购的股份数量为准。本次回购股份的实施期限自公司股东大会审议通 过回购方案之日起 12 个月内。具体内容详见公司 2024 年 12 月 20 日、2025 年 1 月 13 日在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于回购公司股 份方案的公告》(公告编号：2024-13 ...